PanTracer Tissue

In oncology, every decision matters. PanTracer Tissue offers broad, tissue-based CGP designed to support oncologists in delivering personalized care. Aligned with clinical guidelines, this test covers key biomarkers recommended for therapy selection and additional genomic insights for clinical trial enrollment.

• 517 genes, detecting both guideline-recommended and emerging alterations
• DNA + RNA sequencing for optimized fusion detection
• Minimal sample input requirements, minimizing tests failures

COMING SOON